2-(2-Bromo-phenoxy)-propionic acid ethyl ester, 2.5g

(1R,2R,3R,4S,5S,6S,7R,8S)-4-(Hydroxymethyl)cubane-1-carboxylic acid, 98%, 100mg

(7S,8aS)-tert-Butyl 7-hydroxyhexahydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate, 98+%, 1g

Magnesiumtrisilicat, Ph.Eur., USP, 500 g, kunststoffverpackung.

1mol/ L NaPF6 in Diglyme, 500g

tert-Butyl7-fluoro-2-oxo-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate, 95%, 1g

HMBR, 100mg

Levulinic Acid>97.0%(GC)(T)25g

tert-Butyl 3-cyano-3-hydroxyazetidine-1-carboxylate, 97%, 1g

5-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 100mg

3-HYDROXY-4-METHYLTHIAZOLE-2(3H)-THIONE, 95.0%, 250mg

2,4-Dichloro-7-fluoro-5H-pyrrolo[3,2-d]pyrimidine, 95+%, 250mg

(3-Bromopyridin-4-yl)carbamic acid tert-butyl ester, 95.0%, 5g